Operating Expenses تغییر دادن تاریخ
AbbVie USD 11.11B 540M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Alterity Therapeutics Limited AUD 7.78M 3M 2023-06
Amarin USD 87.51M 16.62M 2023-09
Amgen USD 6.93B 2.11B 2023-12
Biogen USD 2.03B 344.1M 2023-12
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Cipla INR 52.34B 1.6B 2023-09
CSL USD 5.19B 142.6M 2023-06
Cytokinetics USD 129.09M 6.45M 2023-12
Daiichi Sankyo JPY 324.48B 17.68B 2023-09
Eli Lilly USD 6.97B 2.08B 2023-12
Esperion Therapeutics USD 61.5M 1.34M 2023-09
Geron USD 54.31M 6.54M 2023-12
Grifols EUR 1.35B 73.17M 2023-09
Halozyme Therapeutics USD 129M 1.25M 2023-12
Heron Therapeutics USD 56.36M 17.8M 2023-09
Intra Cellular Therapies USD 166.2M 10.31M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Merck USD 16.56B 6.35B 2023-12
Minerva Neurosciences USD 6.08M 1.56M 2023-09
Moderna USD 2.8B 1.04B 2023-12
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
PTC Therapeutics USD 438.79M 124.05M 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
United Therapeutics USD 354.6M 72.2M 2023-12
Vanda Pharmaceuticals USD 48.92M 11.57M 2023-06



Esperion Therapeutics هزینه های اجرایی - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2024.